TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$165,51
Dagwisseling
$163,74 - $169,93
Jaarwisseling
$92,14 - $183,00
Markkapitalisasie
22,36 mjd USD
Gemiddelde volume
1,35 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 501,83 m | 36,46% |
Bedryfskoste | 395,94 m | 39,95% |
Netto inkomste | -66,94 m | 0,98% |
Netto winsgrens | -13,34 | 27,42% |
Wins per aandeel | -0,50 | 10,71% |
EBITDA | -69,94 m | -4,00% |
Effektiewe belastingkoers | -0,26% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 991,60 m | 12,31% |
Totale bates | 1,73 mjd | 17,99% |
Totale aanspreeklikheid | 492,69 m | -26,91% |
Totale ekwiteit | 1,24 mjd | — |
Uitstaande aandele | 136,55 m | — |
Prys om te bespreek | 18,15 | — |
Opbrengs op bates | -11,67% | — |
Opbrengs op kapitaal | -14,05% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -66,94 m | 0,98% |
Kontant van bedrywe | 44,45 m | 64,63% |
Kontant van beleggings | -16,82 m | -112,16% |
Kontant van finansiering | 544,00 k | -91,59% |
Netto kontantverandering | 28,18 m | -83,59% |
Beskikbare kontantvloei | 17,51 m | 319,87% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
4 429
